Charles Hugh-Jones's Colleagues at Volastra Therapeutics
Charles Hugh-Jones's Contact Details
HQ
N/A
N/A
Location
Company
Volastra Therapeutics
Volastra Therapeutics
Charles Hugh-Jones's Company Details
Volastra Therapeutics, Inc., is developing novel therapies to treat cancer. Launched from the laboratory of Dr. Lewis Cantley, along with Drs. Olivier Elemento and Samuel Bakhoum, Volastra has identified the mechanisms by which CIN drives the formation and proliferation of solid tumors. Following initial evidence that a patient's CIN status is prognostic and that CIN alters cellular and immune response mechanisms and leads to worse overall survival in mouse models, the company is discovering mechanisms and pathways by which CIN modulates disease to develop novel therapeutics.
Frequently Asked Questions about Charles Hugh-Jones
Charles Hugh-Jones currently works for Volastra Therapeutics.
Charles Hugh-Jones's role at Volastra Therapeutics is CEO.
Charles Hugh-Jones's email address is ***@volastratx.com. To view Charles Hugh-Jones's full email address, please signup to ConnectPlex.
Charles Hugh-Jones works in the Biotechnology industry.
Charles Hugh-Jones's colleagues at Volastra Therapeutics are Reka Letso, Derek Cogan, Ryan Schulz, Christina Eng, Jacqueline Gonzalez, Kassoum Nacro, Marysol Chu and others.
Charles Hugh-Jones's phone number is null